The 2021–2024 HIV Market Intelligence Report examines the procurement, pricing and regulatory environments for antiretroviral medicines in six countries: Argentina, Armenia, Belarus, Brazil, Kazakhstan, and Kyrgyzstan.
The 2021–2024 HIV Market Intelligence Report examines the procurement, pricing and regulatory environments for antiretroviral medicines in six countries: Argentina, Armenia, Belarus, Brazil, Kazakhstan, and Kyrgyzstan.